Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
ZOU Jian-Dong, XIONG Ning-Ning, WANG Xiu-Qin, LIU Fang, JIANG Meng, FU Wei-Min. Data and safety monitoring in clinical trials[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(5): 598-600.
1 ICH harmonised tripartite guideline.E9, statistical principles for clinical trials[S].1998 2 Council for International Organizations of Medical Sciences (CIOM).International Ethical Guidelines for Biomedical Research Involving Human Subjects[S].2002 3 卜擎燕, 熊宁宁, 吴静.临床试验中对照选择的国际伦理要求[J].中国临床药理学与治疗学, 2003;8(2):215-8 4 National Institutes of Health.Data and Safety Monitoring Board(DSMB) Guidelines[S].2001 5 National Institute on Drug Abuse (NIDA).Data and Safety Monitoring Board Standard Operating Procedures[S].2000 6 National Cancer Institute of United States.Policy of The National Cancer Institute for Data and Safety Monitoring of Clinical Trials[S].1999
WANG Yi-Bing, XIONG Ning-Ning, BO Qing-Yan, ZOU Jian-Dong, JIANG Meng, LIU Fang, FU Wei-Min.
Measuring data quality of clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(6): 717-720.